Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BridgeBio
Pharma
For $100M, BridgeBio partners with Kyowa Kirin on infigratinib
With an upfront payment of $100 million, Kyowa Kirin has bought into a partnership with BridgeBio to develop and commercialize infigratinib in Japan.
Kevin Dunleavy
Feb 7, 2024 12:53pm
Pfizer's tafamidis will hold its own against new meds: analysts
Sep 18, 2023 3:05pm
Rare disease player BridgeBio draws buyout interest: Bloomberg
Mar 28, 2023 11:10am
BridgeBio partner Helsinn pulls Truseltiq for 'business reasons'
Oct 13, 2022 12:54pm
A third FGFR inhibitor is wading into the bile duct cancer arena
Oct 3, 2022 10:30am
2021 drug approvals: Biopharma delivered 55 new drugs
Jan 4, 2022 3:00am
